Reactive glia show increased immunoproteasome activity in Alzheimer’s disease

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Innate immune recognition

Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · see citing works

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB

Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,097 · see citing works

Protein degradation and protection against misfolded or damaged proteins.

Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088 · see citing works

Microglia in neurodegenerative disease

Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · see citing works

Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 3× · see citing works

Impaired Proteasome Function in Alzheimer's Disease

Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · see citing works

CD14 is required for MyD88-independent LPS signaling

Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., et al. (2005) · Nature Immunology · doi:10.1038/ni1207 · Cited by 671 · see citing works

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

Muchamuel, T., Basler, M., Aujay, M. A., Suzuki, É., Kalim, K. W., Lauer, C., Sylvain, C., Ring, E. R., Shields, J., Jiang, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1978 · Cited by 603 · see citing works

CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation

Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · see citing works

γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes

Gaczynska, M. E., Rock, K. L., & Goldberg, A. L. (1993) · Nature · doi:10.1038/365264a0 · Cited by 571 · see citing works

Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress

Seifert, U., Biały, Ł. P., Ebstein, F., Bech‐Otschir, D., Beling, A., Schröter, F., Prozorovski, T., Lange, N., Steffen, J., Rieger, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.036 · Cited by 554 · see citing works

Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease

Keck, S., Nitsch, R., Grune, T., & Ullrich, O. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01642.x · Cited by 483 · see citing works

TLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation

Liu, S., Liu, Y., Hao, W., Wolf, L., Kiliaan, A. J., Penke, B., Rübe, C. E., Walter, J., Heneka, M. T., Hartmann, T., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101121 · Cited by 439 · see citing works

Neuroinflammatory processes in Alzheimer’s disease

Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433 · see citing works

Aβ inhibits the proteasome and enhances amyloid and tau accumulation

Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., & LaFerla, F. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.014 · Cited by 384 · see citing works

Sequence of Aβ-protein deposition in the human medial temporal lobe

Thal, D. R., Rüb, U., Schultz, C., Sassin, I., Ghebremedhin, E., Del Tredici, K., Braak, E., & Braak, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.733 · Cited by 370 · see citing works

Proteasomes in immune cells: more than peptide producers?

Groettrup, M., Kirk, C. J., & Basler, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2687 · Cited by 345 · see citing works

LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide

Liu, Y., Walter, S., Stagi, M., Cherny, D., Letièmbre, M., Schulz‐Schaeffer, W., Heine, H., Penke, B., Neumann, H., & Fassbender, K. C. (2005) · Brain · doi:10.1093/brain/awh531 · Cited by 344 · see citing works

Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide Substrates

Kisselev, A. F., & Goldberg, A. L. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)98030-0 · Cited by 343 · see citing works

Patterns of gliosis in alzheimer's disease and aging cerebrum

Beach, T. G., Walker, R., & McGeer, E. G. (1989) · Glia · doi:10.1002/glia.440020605 · Cited by 337 · see citing works

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome

Parlati, F., Lee, S. H., Aujay, M. A., Suzuki, É., Levitsky, K., Lorens, J. B., Micklem, D., Ruurs, P., Sylvain, C., Lu, Y., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223677 · Cited by 326 · see citing works

The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes

Pickering, A. M., Koop, A. L., Teoh, C., Ermak, G., Grune, T., & Davies, K. J. A. (2010) · Biochemical Journal · doi:10.1042/bj20100878 · Cited by 319 · see citing works

β-Amyloid Accumulation Impairs Multivesicular Body Sorting by Inhibiting the Ubiquitin-Proteasome System

Almeida, C. G., Takahashi, R. H., & Gouras, G. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5078-05.2006 · Cited by 316 · see citing works

Mice completely lacking immunoproteasomes show major changes in antigen presentation

Kincaid, E., Che, J. W., York, I. A., Escobar, H., Reyes‐Vargas, E., Delgado, J. C., Welsh, R. M., Karow, M. L., Murphy, A. J., Valenzuela, D. M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2203 · Cited by 291 · see citing works

Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β_1–42and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease

Richard, K. L., Filali, M., Préfontaine, P., & Rivest, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1146-08.2008 · Cited by 261 · see citing works

Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation

Hensley, K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1414 · Cited by 250 · see citing works

Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome

Basler, M., Dajee, M., Moll, C., Groettrup, M., & Kirk, C. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903182 · Cited by 237 · see citing works

A transgenic mouse model of the ubiquitin/proteasome system

Lindsten, K., Menéndez-Benito, V., Masucci, M. G., & Dantuma, N. P. (2003) · Nature Biotechnology · doi:10.1038/nbt851 · Cited by 234 · see citing works

Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice

DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223 · see citing works

Displacement of housekeeping proteasome subunits by MHC‐encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex.

Früh, K., Gossen, M., Wang, K., Bujard, H., Peterson, P. A., & Yang, Y. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06625.x · Cited by 218 · see citing works

Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains

Mishto, M., Bellavista, E., Santoro, A., Stolzing, A., Ligorio, C., Nacmias, B., Spazzafumo, L., Chiappelli, M., Licastro, F., Sorbi, S., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.004 · Cited by 210 · see citing works

APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1

Jankowsky, J. L., Slunt, H. H., Gonzales, V., Jenkins, N. A., Copeland, N. G., & Borchelt, D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.008 · Cited by 189 · see citing works

Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimers Disease

Ruan, L., Kang, Z., Pei, G., & Le, Y. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147070 · Cited by 169 · see citing works

Amyloid peptide attenuates the proteasome activity in neuronal cells

Oh, S., Hong, H., Hwang, E., Sim, H. J., Lee, W., Shin, S. J., & Mook‐Jung, I. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.07.006 · Cited by 166 · see citing works

Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis

Schmidt, N., Gonzalez, E., Visekruna, A., Kühl, A. A., Loddenkemper, C., Mollenkopf, H., Kaufmann, S. H. E., Steinhoff, U., & Joeris, T. (2010) · Gut · doi:10.1136/gut.2009.203554 · Cited by 166 · see citing works

Protein quality control in Alzheimer's disease by the ubiquitin proteasome system

de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 152 · see citing works

Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model

Kamphuis, W., Orre, M., Kooijman, L., Dahmen, M., & Hol, E. M. (2012) · Glia · doi:10.1002/glia.22295 · Cited by 137 · see citing works

Stability of endogenous reference genes in postmortem human brains for normalization of quantitative real-time PCR data: comprehensive evaluation using geNorm, NormFinder, and BestKeeper

Wang, Q., Ishikawa, T., Michiue, T., Zhu, B.-L., Guan, D., & Maeda, H. (2012) · International Journal of Legal Medicine · doi:10.1007/s00414-012-0774-7 · Cited by 137 · see citing works

Endoplasmic reticulum stress activates autophagy but not the proteasome in neuronal cells: implications for Alzheimer's disease

Nijholt, D. A. T., de Graaf, T. R., van Haastert, E. S., Oliveira, A. O., Berkers, C. R., Zwart, R., Ovaa, H., Baas, F., Hoozemans, J. J. M., & Scheper, W. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2010.176 · Cited by 136 · see citing works

PPARγ Agonist Curcumin Reduces the Amyloid-β-Stimulated Inflammatory Responses in Primary Astrocytes

Wang, H., Zhao, Y., Zhang, S., Liu, G.-D., Kang, W., Tang, H., Ding, J., & Chen, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091336 · Cited by 124 · see citing works

Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer’s disease

Aso, E., Lomoio, S., López‐González, I., Joda, L., Carmona, M., Fernández‐Yagüe, N., Moreno, J., Juvés, S., Pujol, A., Pamplona, R., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00560.x · Cited by 118 · see citing works

Profiling Proteasome Activity in Tissue with Fluorescent Probes

Berkers, C. R., van Leeuwen, F. W. B., Groothuis, T. A., Peperzak, V., van Tilburg, E. W., Borst, J. G., Neefjes, J., & Ovaa, H. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700256 · Cited by 114 · see citing works

Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study

Durrenberger, P. F., Fernando, F. S., Magliozzi, R., Kashefi, S. N., Bonnert, T. P., Ferrer, I., Seilhean, D., Nait‐Oumesmar, B., Schmitt, A., Gebicke‐Haerter, P. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1027-z · Cited by 113 · see citing works

Deletion of CD14 Attenuates Alzheimer's Disease Pathology by Influencing the Brain's Inflammatory Milieu

Reed-Geaghan, E. G., Reed, Q. W., Cramer, P. E., & Landreth, G. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2637-10.2010 · Cited by 104 · see citing works

Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune Responses

Hensley, S. E., Zanker, D. J., Dolan, B. P., David, A., Hickman, H. D., Embry, A. C., Skon-Hegg, C., Grebe, K. M., Griffin, T. A., Chen, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903003 · Cited by 102 · see citing works

A β 1-42 Induces Mild Endoplasmic Reticulum Stress in an Aggregation State–Dependent Manner

Chafekar, S. M., Hoozemans, J. J. M., Zwart, R., Baas, F., & Scheper, W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1797 · Cited by 97 · see citing works

Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates

Rodgers, K. J., & Dean, R. T. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00391-6 · Cited by 94 · see citing works

The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptide

Schubert, D. A., Soucek, T., & Blouw, B. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06712.x · Cited by 89 · see citing works

Vasoactive intestinal peptide protects against β‐amyloid‐induced neurodegeneration by inhibiting microglia activation at multiple levels

Delgado, M., Varela, N., & González‐Rey, E. (2008) · Glia · doi:10.1002/glia.20681 · Cited by 85 · see citing works

Cognitive and Behavioral Consequences of Impaired Immunoregulation in Aging

Corona, A. W., Fenn, A. M., & Godbout, J. P. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9313-4 · Cited by 84 · see citing works

Recent advances in (patho)physiology of astroglia

Verkhratsky, A., & Parpura, V. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.108 · Cited by 82 · see citing works

Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease

Cameron, B., Tse, W., Lamb, R., Li, X., Lamb, B. T., & Landreth, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1729-12.2012 · Cited by 75 · see citing works

Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome

Luo, Z.-F., Qi, W., Feng, B., Mu, J., Zeng, W., Guo, Y., Pang, Q., Ye, Z.-L., Liu, L., & Fa-huan, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2010.12.023 · Cited by 75 · see citing works

Immunoproteasome responds to injury in the retina and brain

Ferrington, D. A., Hussong, S. A., Roehrich, H., Kapphahn, R. J., Kavanaugh, S. M., Heuss, N. D., & Gregerson, D. S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05345.x · Cited by 73 · see citing works

TLR2 Hypersensitivity of Astrocytes as Functional Consequence of Previous Inflammatory Episodes

Henn, A., Kirner, S., & Leist, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002787 · Cited by 67 · see citing works

Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population

Mishto, M., Bellavista, E., Ligorio, C., Textoris‐Taube, K., Santoro, A., Giordano, M., D’Alfonso, S., Listı̀, F., Nacmias, B., Cellini, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009287 · Cited by 62 · see citing works

GFAPδ Expression in Glia of the Developmental and Adolescent Mouse Brain

Mamber, C., Kamphuis, W., Haring, N. L., Peprah, N., Middeldorp, J., & Hol, E. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052659 · Cited by 61 · see citing works

Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome

Fergusson, J., Landon, M., Lowe, J. S., Dawson, S. P., Layfield, R., Hanger, D. P., & Mayer, R. J. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13192-x · Cited by 53 · see citing works

Persistent Hijacking of Brain Proteasomes in HIV-Associated Dementia

Nguyen, T. P., Soukup, V. M., & Gelman, B. B. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090390 · Cited by 50 · see citing works

Intermediate filament transcription in astrocytes is repressed by proteasome inhibition

Middeldorp, J., Kamphuis, W., Sluijs, J. A., Achoui, D., Leenaars, C. H. C., Feenstra, M. G. P., van Tijn, P., Fischer, D. F., Berkers, C. R., Ovaa, H., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-127696 · Cited by 45 · see citing works

The Immunoproteasomes Regulate LPS-Induced TRIF/TRAM Signaling Pathway in Murine Macrophages

Reis, J. C., Hassan, F., Guan, X. Q., Shen, J., Monaco, J. J., Papasian, C. J., Qureshi, A. A., Way, C. W. V., Vogel, S. N., Morrison, D. C., et al. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9183-7 · Cited by 33 · see citing works

Immunoproteasome expression is induced in mesial temporal lobe epilepsy

Mishto, M., Ligorio, C., Bellavista, E., Martucci, M., Santoro, A., Giulioni, M., Marucci, G., & Franceschi, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.117 · Cited by 31 · see citing works

The immunoproteasome in steatohepatitis: Its role in Mallory–Denk body formation

French, B. A., Oliva, J., Bardag‐Gorce, F., & French, S. W. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.01.004 · Cited by 26 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Reactive astrocyte nomenclature, definitions, and future directions

Escartin, C., Galea, E., Lakatos, A., O’Callaghan, J. P., Petzold, G. C., Serrano-Pozo, A., Steinhäuser, C., Volterra, A., Carmignoto, G., Agarwal, A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00783-4 · Cited by 2,533 · see citing works

Astrocyte reactivity and reactive astrogliosis: costs and benefits

Pekny, M., & Pekna, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00041.2013 · Cited by 934 · see citing works

Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system

Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917 · see citing works

Astrocytes: a central element in neurological diseases

Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755 · see citing works

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza‐Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 706 · see citing works

Elusive roles for reactive astrocytes in neurodegenerative diseases

Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453 · see citing works

Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging

Soreq, L., Rose, J., Soreq, E., Hardy, J., Trabzuni, D., Cookson, M. R., Smith, C., Ryten, M., Patani, R., & Ule, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.011 · Cited by 419 · see citing works

Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction

Orre, M., Kamphuis, W., Osborn, L. M., Jansen, A. H. P., Kooijman, L., Bossers, K., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.004 · Cited by 394 · see citing works

Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities

Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 373 · see citing works

The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution

Dantuma, N. P., & Bott, L. C. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00070 · Cited by 336 · see citing works

Deciphering the astrocyte reaction in Alzheimer's disease

Perez-Nievas, B. G., & Serrano-Pozo, A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00114 · Cited by 282 · see citing works

Long-Term Neuroinflammation Induced by Influenza A Virus Infection and the Impact on Hippocampal Neuron Morphology and Function

Hosseini, S., Wilk, E., Michaelsen-Preusse, K., Gerhauser, I., Baumgärtner, W., Geffers, R., Schughart, K., & Korte, M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1740-17.2018 · Cited by 236 · see citing works

SQSTM1/p62: a potential target for neurodegenerative disease

Ma, S., Attarwala, I. Y., & Xie, X.-Q. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00516 · Cited by 185 · see citing works

Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration

Spielman, L. J., Little, J. P., & Klegeris, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.004 · Cited by 182 · see citing works

Microglial activation in the pathogenesis of Huntington's disease

Yang, H.-M., Yang, S., Huang, S.-S., Tang, B.-S., & Guo, J.-F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00193 · Cited by 151 · see citing works

The ubiquitin proteasome system in glia and its role in neurodegenerative diseases

Jansen, A. H. P., Reits, E. A., & Hol, E. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00073 · Cited by 127 · see citing works

Diversity of astroglial responses across human neurodegenerative disorders and brain aging

Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 123 · see citing works

Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell‐type‐specific

Jansen, A. H. P., van Hal, M., den Kelder, I. C. O., Meier, R. T., Ruiter, A. A. D., Schut, M. H., Smith, D. L., Grit, C., Brouwer, N., Kamphuis, W., et al. (2016) · Glia · doi:10.1002/glia.23050 · Cited by 124 · see citing works

The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease

Gadhave, K., Bolshette, N. B., Ahire, A., Pardeshi, R., Thakur, K. K., Trandafir, C.-M., Istrate, A., Ahmed, S., Lahkar, M., Muresanu, D. F., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12817 · Cited by 119 · see citing works

Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases

Chondrogianni, N., Voutetakis, K., Καπετάνου, Μ., Delitsikou, V., Papaevgeniou, N., Sakellari, M., Lefaki, M., Filippopoulou, K., & Gonos, E. S. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.003 · Cited by 112 · see citing works

Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer

Morozov, A. V., & Карпов, В. Л. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00761 · Cited by 111 · see citing works

Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes

Möhle, L., Israël, N., Paarmann, K., Krohn, M., Pietkiewicz, S., Müller, A. J., Lavrik, I. N., Buguliskis, J. S., Schott, B. H., Schlüter, D., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0293-8 · Cited by 101 · see citing works

Identification of Differentially Expressed Genes through Integrated Study of Alzheimer’s Disease Affected Brain Regions

Puthiyedth, N., Riveros, C., Berretta, R. E., & Moscato, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152342 · Cited by 103 · see citing works

The Proteasome and Oxidative Stress in Alzheimer's Disease

Bonet-Costa, V., Pomatto, L. C.-D., & Davies, K. J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6802 · Cited by 99 · see citing works

The emerging roles of protein homeostasis‐governing pathways in Alzheimer's disease

Cheng, J., North, B. J., Zhang, T., Dai, X., Tao, K., Guo, J., & Wei, W. (2018) · Aging Cell · doi:10.1111/acel.12801 · Cited by 96 · see citing works

Proteasome activation delays aging in vitro and in vivo

Chondrogianni, N., Sakellari, M., Lefaki, M., Papaevgeniou, N., & Gonos, E. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.031 · Cited by 94 · see citing works

BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease

Wu, Y., Gong, Y., Luan, Y., Li, Y., Liu, J., Yue, Z., Yuan, B., Sun, J., Xie, C., Li, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901984r · Cited by 86 · see citing works

The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease

Davidson, K., & Pickering, A. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1124907 · Cited by 84 · see citing works

Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases

Sonninen, T.-M., Goldsteins, G., Laham-Karam, N., Koıstınaho, J., & Lehtonen, Š. (2020) · Cells · doi:10.3390/cells9102183 · Cited by 84 · see citing works

Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition

Marlatt, M. W., Bauer, J., Aronica, E., van Haastert, E. S., Hoozemans, J. J. M., Joels, M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/693851 · Cited by 83 · see citing works

TLR4 mediates the impairment of ubiquitin-proteasome and autophagy-lysosome pathways induced by ethanol treatment in brain

Pla, A., Pascual, M., Renau‐Piqueras, J., & Guerri, C. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.46 · Cited by 77 · see citing works

Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls

Ayyadevara, S., Balasubramaniam, M., Parcon, P. A., Barger, S. W., Griffin, W. S. T., Alla, R., Tackett, A. J., Mackintosh, S. G., Petricoin, E. F., Zhou, W., et al. (2016) · Aging Cell · doi:10.1111/acel.12501 · Cited by 76 · see citing works

Astragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases

Elkader, H. A. E. A., Essawy, A. E., & Al‐Shami, A. S. (2022) · Phytochemistry · doi:10.1016/j.phytochem.2022.113293 · Cited by 75 · see citing works

On the Role of the Immunoproteasome in Protein Homeostasis

Basler, M., & Groettrup, M. (2021) · Cells · doi:10.3390/cells10113216 · Cited by 72 · see citing works

Altered Cholesterol Homeostasis in Huntington’s Disease

Kacher, R., Mounier, C., Caboche, J., & Bétuing, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.797220 · Cited by 72 · see citing works

Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us

Hirbec, H., Noristani, H. N., & Perrin, F. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00227 · Cited by 69 · see citing works

Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the <scp>APPswePS1dE9</scp> mouse model

Smit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021) · Glia · doi:10.1002/glia.23981 · Cited by 71 · see citing works

A Sentinel in the Crosstalk Between the Nervous and Immune System: The (Immuno)-Proteasome

Limanaqi, F., Biagioni, F., Gaglione, A., Busceti, C. L., & Fornai, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00628 · Cited by 69 · see citing works

Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke

Chen, X., Zhang, X., Wang, Y., Lei, H., Su, H., Zeng, J., Pei, Z., & Huang, R. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.586 · Cited by 68 · see citing works

Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer’s disease-like APPPS1 mice

Wagner, L. K., Gilling, K. E., Schormann, E., Kloetzel, P. M., Heppner, F. L., Krüger, E., & Prokop, S. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0453-5 · Cited by 66 · see citing works

Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer’s Disease

Hegde, A. N., Smith, S. G., Duke, L. M., Pourquoi, A., & Vaz, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00324 · Cited by 63 · see citing works

Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice

MacPherson, R. E. K., Baumeister, P., Peppler, W. T., Wright, D. C., & Little, J. P. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00299.2015 · Cited by 58 · see citing works

Multispectral Imaging

Mansfield, J. R. (2013) · Veterinary Pathology · doi:10.1177/0300985813506918 · Cited by 55 · see citing works

Resveratrol-mediated cleavage of amyloid β1–42 peptide: potential relevance to Alzheimer's disease

Al-Edresi, S., Alsalahat, I., Freeman, S., Aojula, H. S., & Penny, J. I. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.04.012 · Cited by 53 · see citing works

The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders

Zerfas, B. L., Maresh, M. E., & Trader, D. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01226 · Cited by 53 · see citing works

TSG (2,3,4’ ,5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia

Huang, C., Wang, Y., Wang, J., Yao, W., Chen, X., & Zhang, W. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-129 · Cited by 51 · see citing works

The biomarkers of immune dysregulation and inflammation response in Parkinson disease

Chen, L., Mo, M., Li, G., Cen, L., Wei, L., Xiao, Y., Chen, X., Li, S., Yang, X., Qu, S., et al. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0063-3 · Cited by 51 · see citing works

Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms

Sarroca, S., Gatius, A., Rodrı́guez-Farré, E., Vı́lchez, D., Pallàs, M., Griñán‐Ferré, C., Sanfeliu, C., & Corpas, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108569 · Cited by 52 · see citing works

Protein Modifications with Ubiquitin as Response to Cerebral Ischemia-Reperfusion Injury

Hochrainer, K. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0567-x · Cited by 50 · see citing works

Astragalus polysaccharide attenuates lipopolysaccharide-induced inflammatory responses in microglial cells: regulation of protein kinase B and nuclear factor-κB signaling

Luo, T., Qin, J., Liu, M., Luo, J., Ding, F., Wang, M., & Zheng, L. (2015) · Inflammation Research · doi:10.1007/s00011-015-0798-9 · Cited by 47 · see citing works

Proteasome Subunits Involved in Neurodegenerative Diseases

Fernández-Cruz, I., & Reynaud, E. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.007 · Cited by 48 · see citing works

The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis

Woo, M. S., Brand, J., Bal, L. C., Moritz, M., Walkenhorst, M., Vieira, V., Ipenberg, I., Rothammer, N., Wang, M., Dogan, B., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.029 · Cited by 46 · see citing works

The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies

Bhattarai, S., Ghannam, K., Krause, S., Benvéniste, O., Marg, A., de Bruin, G., Xin, B., Overkleeft, H. S., Spuler, S., Stenzel, W., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.08.004 · Cited by 46 · see citing works

Abundant kif21b is associated with accelerated progression in neurodegenerative diseases

Kreft, K. L., van Meurs, M., Wierenga‐Wolf, A. F., Melief, M., van Strien, M. E., Hol, E. M., Oostra, B. A., Laman, J. D., & Hintzen, R. Q. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0144-4 · Cited by 44 · see citing works

TCF11/Nrf1-Mediated Induction of Proteasome Expression Prevents Cytotoxicity by Rotenone

Sotzny, F., Schormann, E., Kühlewindt, I., Koch, A., Brehm, A., Goldbach‐Mansky, R. T., Gilling, K. E., & Krüger, E. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6539 · Cited by 45 · see citing works

Molecular Insight Into the IRE1α-Mediated Type I Interferon Response Induced by Proteasome Impairment in Myeloid Cells of the Brain

Studencka‐Turski, M., Çetin, G., Junker, H., Ebstein, F., & Krüger, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02900 · Cited by 44 · see citing works

Sarsasapogenin‐ AA 13 ameliorates Aβ‐induced cognitive deficits via improving neuroglial capacity on Aβ clearance and antiinflammation

Huang, C., Dong, D., Jiao, Q., Pan, H., Ma, L., & Wang, R. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12697 · Cited by 42 · see citing works

PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke

Guo, Y., Chen, X., Li, D., Liu, H., Ding, Y., Han, R., Shi, Y., & Ma, X. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13132 · Cited by 42 · see citing works

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders

Ugras, S. E., Daniels, M. J., Fazelinia, H., Gould, N. S., Yocum, A. K., Luk, K. C., Luna, E., Ding, H., McKennan, C. G., Seeholzer, S. H., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.007 · Cited by 40 · see citing works

The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome

Smith, B. C., Sinyuk, M., Jenkins, J. E., Psenicka, M. W., & Williams, J. L. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01861-x · Cited by 40 · see citing works

Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia

Luca, A., Calandra, C., & Luca, M. (2018) · Aging and Disease · doi:10.14336/ad.2018.0201 · Cited by 39 · see citing works

AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders

Pan, X., Yun, J., Coban‐Akdemir, Z., Jiang, X., Wu, E., Huang, J. H., Sahni, N., & Yi, S. S. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.004 · Cited by 36 · see citing works

Inhibition of immunoproteasome promotes angiogenesis via enhancing hypoxia-inducible factor-1α abundance in rats following focal cerebral ischaemia

Chen, X., Zhang, X., Chen, T., Jiang, X., Wang, X., Lei, H., & Wang, Y. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.04.009 · Cited by 36 · see citing works

LMP2 Inhibitors as a Potential Treatment for Alzheimer’s Disease

Bhattarai, D., Lee, M. J., Baek, A., Yeo, I. J., Miller, Z. C., Baek, Y. M., Lee, S., Kim, D., Hong, J. T., & Kim, K. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00416 · Cited by 36 · see citing works

Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age

Hulshof, L. A., Frajmund, L. A., van Nuijs, D., van der Heijden, D. C. N., Middeldorp, J., & Hol, E. M. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.12.009 · Cited by 35 · see citing works

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases

Feringa, F. M., Koppes-den Hertog, S. J., Wang, L. Y., Derks, R. J. E., Kruijff, I., Erlebach, L., Heijneman, J., Miramontes, R., Pömpner, N., Blomberg, N., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01365-z · Cited by 56 · see citing works

Current Understanding on the Role of Standard and Immunoproteasomes in Inflammatory/Immunological Pathways of Multiple Sclerosis

Bellavista, E., Santoro, A., Galimberti, D., Comi, C., Luciani, F., & Mishto, M. (2014) · Autoimmune Diseases · doi:10.1155/2014/739705 · Cited by 33 · see citing works

The Proteasome Function Reporter GFPu Accumulates in Young Brains of the APPswe/PS1dE9 Alzheimer’s Disease Mouse Model

Liu, Y., Hettinger, C. L., Zhang, D., Rezvani, K. S., Wang, X., & Wang, H. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-0022-9 · Cited by 33 · see citing works

On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer’s Disease

Kriška, J., Heřmanová, Z., Knotek, T., Turečková, J., & Anděrová, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189689 · Cited by 33 · see citing works

Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer’s disease

Jiang, S., Srikanth, M., Serpe, R., Yavari, S., Gaur, P., Collins, G. A., Soni, R. K., Menon, V., & Myeku, N. (2025) · Brain · doi:10.1093/brain/awaf222 · Cited by 38 · see citing works

A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer’s disease

Yeo, I. J., Lee, M. J., Baek, A., Miller, Z. C., Bhattarai, D., Baek, Y. M., Jeong, H. J., Kim, Y. K., Kim, D., Hong, J. T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54846-z · Cited by 29 · see citing works

Dysregulation of the (immuno)proteasome pathway in malformations of cortical development

van Scheppingen, J., Broekaart, D. W. M., Scholl, T. O., Zuidberg, M. R. J., Anink, J. J., Spliet, W. G. M., van Rijen, P. C., Czech, T., Hainfellner, J. A., Feucht, M., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0662-z · Cited by 28 · see citing works

Immunoproteasomes control activation of innate immune signaling and microglial function

Çetin, G., Studencka‐Turski, M., Venz, S., Schormann, E., Junker, H., Hammer, E., Völker, U., Ebstein, F., & Krüger, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.982786 · Cited by 27 · see citing works

Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones

Elkharaz, J., Ugun‐Klusek, A., Constantin‐Teodosiu, D., Lawler, K., Mayer, R. J., Billett, E. E., Lowe, J. S., & Bedford, L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.002 · Cited by 26 · see citing works

Immunoproteasome subunit PSMB8 regulates microglia-mediated neuroinflammation upon manganese exposure by PERK signaling

Guo, T., Liu, C., Yang, C., Wu, J., Su, P., & Chen, J. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112951 · Cited by 26 · see citing works

Acute exercise and brain BACE 1 protein content: a time course study

Yang, A. J. T., Hayward, G. C., & MacPherson, R. E. K. (2019) · Physiological Reports · doi:10.14814/phy2.14084 · Cited by 26 · see citing works

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease

Yeung, J. H. Y., Palpagama, T. H., Wood, O. W. G., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702824 · Cited by 26 · see citing works

P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease

Bianchi, C., Alvarez‐Castelao, B., Sebastián‐Serrano, Á., Lauro, C. D., Soria-Tobar, L., Nicke, A., Engel, T., & Dı́az-Hernández, M. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01258-x · Cited by 25 · see citing works

Current landscape of the immunoproteasome: implications for disease and therapy

Zou, Z., Hao, Y., Tao, Z., Ye, W., Luo, Z., Li, X., Li, R., Zheng, K., Xia, J., Guo, C., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02698-0 · Cited by 27 · see citing works

At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention

Tundo, G. R., Sbardella, D., Oddone, F., Kudriaeva, A. A., Lacal, P. M., Belogurov, A. A., Graziani, G., & Marini, S. (2021) · Cancers · doi:10.3390/cancers13194852 · Cited by 24 · see citing works

A patent review of immunoproteasome inhibitors

Ogorevc, E., Schiffrer, E. S., Sosič, I., & Gobec, S. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1484904 · Cited by 24 · see citing works

Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease

Church, T. R., & Margolis, S. S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1531797 · Cited by 24 · see citing works

The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis

French, T., Israel, N., Düsedau, H. P., Tersteegen, A., Steffen, J., Cammann, C., Topfstedt, E., Dieterich, D. C., Schüler, T., Seifert, U., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.619465 · Cited by 22 · see citing works

Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease

Lee, M. J., Bhattarai, D., Jang, H., Baek, A., Yeo, I. J., Lee, S., Miller, Z. C., Lee, S., Hong, J. T., Kim, D., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00291 · Cited by 22 · see citing works

Immortalized Alzheimer’s Disease Astrocytes: Characterization of Their Proteolytic Systems

Gong, C., Bonfili, L., Zheng, Y., Cecarini, V., Cuccioloni, M., Angeletti, M., Dematteis, G., Tapella, L., Genazzani, A. A., Lim, D., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03231-z · Cited by 22 · see citing works

Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis

Grimm, M. O. W., Lauer, A. A., Grösgen, S., Thiel, A., Lehmann, J., Winkler, J., Janitschke, D., Herr, C., Beißwenger, C., Bals, R., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.015 · Cited by 22 · see citing works

Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective

Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 21 · see citing works

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4Preprint

Feringa, F. M., Hertog, S. K.-D., Wang, L. Y., Derks, R. J. E., Kruijff, I. D., Erlebach, L., Heijneman, J., Miramontes, R., Pömpner, N., Blomberg, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.01.601474 · Cited by 21 · see citing works

Immunoproteasome is up-regulated in rotenone-induced Parkinson’s disease rat model

Sun, C., Jia, G., Wang, X., Wang, Y., & Liu, Y. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135360 · Cited by 20 · see citing works

Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain

Ospina, S. R., Blazier, D. M., Criado‐Marrero, M., Gould, L. A., Gebru, N. T., Beaulieu‐Abdelahad, D., Wang, X., Remily-Wood, E. R., Chaput, D., Stevens, S. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020851 · Cited by 19 · see citing works

Noncanonical inheritance of phenotypic information by protein amyloids

Eroglu, M., Zocher, T., McAuley, J., Webster, R., Xiao, M. Z. X., Yu, B., Mok, C. A., & Derry, W. B. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01494-9 · Cited by 26 · see citing works

TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo

Lee-Gosselin, A., Jury-Garfe, N., You, Y., Dabin, L., Soni, D., Dutta, S., Rochet, J.-C., Kim, J., Oblak, A. L., & Lasagna-Reeves, C. A. (2023) · Cells · doi:10.3390/cells12121597 · Cited by 19 · see citing works

PSMA2 knockdown impacts expression of proteins involved in immune and cellular stress responses in human lung cells

Rashid, M., Lorzadeh, S., Gao, A., Ghavami, S., & Coombs, K. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166617 · Cited by 18 · see citing works

The platelet transcriptome and proteome in Alzheimer’s disease and aging: an exploratory cross-sectional study

de Sousa, D. M. B., Poupardin, R., Villeda, S., Schroer, A. B., Fröhlich, T., Frey, V., Staffen, W., Mrowetz, H., Altendorfer, B., Unger, M. S., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1196083 · Cited by 20 · see citing works

Methods for 20S Immunoproteasome and 20S Constitutive Proteasome Determination Based on SPRI Biosensors

Sankiewicz, A., Markowska, A., Łukaszewski, Z., Puzan, B., & Gorodkiewicz, E. (2017) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-017-0478-7 · Cited by 17 · see citing works

Activation of the immunoproteasome protects SH-SY5Y cells from the toxicity of rotenone

Sun, C., Mo, M., Wang, Y., Yu, W., Song, C., Wang, X., Chen, S., & Liu, Y. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.03.004 · Cited by 17 · see citing works

Omega-3 PUFAs Suppress IL-1β-Induced Hyperactivity of Immunoproteasomes in Astrocytes

Zgórzyńska, E., Dziedzic, B., Markiewicz, M., & Walczewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115410 · Cited by 17 · see citing works

Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease

Song, F., Qian, Y., Peng, X., Han, G., Wang, J., Bai, Z., Crack, P. J., & Lei, H. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.015 · Cited by 17 · see citing works

Association between plasma immunoproteasome and 90-day prognosis after first-ever ischemic stroke

Wang, Y., Chen, X., Fu, M., Wan, S.-F., & Zhang, X. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295344 · Cited by 16 · see citing works

Perturbations of proteostasis networks in Alzheimer´s disease: Focus on the ubiquitin proteasome system

Schormann, E. (2019) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-1860

The role of immunoproteasomes in modulating neuro‐inflammation in Alzheimer’s Disease

Kumar, M., Jiang, S., Lorman, D., David, L., Soni, R. K., Kissner, M. D., Yang, M., & Myeku, N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.086577

Modulation of the Immunoproteasome Affects Pathological Tau Aggregation in Alzheimer’s Disease

Nashman, Z., Runyan, A. M., Sydney, E. J., & Myeku, N. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.071413

Impaired Proteasome Function in Alzheimer's Disease

Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · see citing works

The immunoproteasome in Alzheimer’s disease: a dual regulator of tau pathology and microglial senescence

Shokr, M. M., & Abdelaziz, A. M. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02393-1